Sino Biopharmaceutical Limited: VOLUNTARY ANNOUNCEMENT - COMPLETION OF ENROLLMENT OF THE FIRST PATIENT IN PHASE III CLINICAL TRIAL OF TECOTABART VEDOTIN "CLDN18.2 ADC" FOR FIRST-LINE TREATMENT OF GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

If the user is currently logged in, clicking "Log Out User" will end their session, requiring them to log back in again. Use this option if you made any changes for the user that will not take effect until the next time they log in.

If you do not wish to disrupt the user's current session, you may log off by clicking "Just End My Session".